Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chevallier

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 28, 2009
[Value of a new thickened formula in infants with regurgitations]B Chevallier, V Fournier, B Logre, et al.
Bulletin Du Cancer|January 1, 1989
[What are the prognostic factors in operable breast cancer without histologic axillary lymph node invasiveness. Results of an uni- and multifactorial analysis]B Chevallier, F Heintzman, V Mosseri, et al.
American Journal of Clinical Oncology|April 1, 1994
Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study GroupT Conroy, P Cappelaere, M Fabbro, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of CancerP Hurteloup, J P Armand, M Schneider, et al.
Cancer|December 15, 1988
Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysisB Chevallier, F Heintzmann, V Mosseri, et al.
Bulletin Du Cancer|July 1, 1993
[Treatment of advanced breast cancer in postmenopausal women with droloxifene: results of a double-blind phase II trial for dose determination]B Chevallier, M Spielmann, M Marty, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2003
[Marfan syndrome]G Jondeau, C Boileau, B Chevallier, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1997
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapyB Chevallier, P Cappelaere, T Splinter, et al.
European Urology|January 1, 1993
Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trialC Chevreau, J P Droz, J L Pico, et al.
HIV Medicine|April 4, 2026
Late HIV diagnosis and subsequent time to antiretroviral initiation and viral suppression in a large London HIV centreTheodore R B Chevallier, Fiona C Lampe, Margaret A Johnson, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 28, 2009
[Value of a new thickened formula in infants with regurgitations]B Chevallier, V Fournier, B Logre, et al.
Bulletin Du Cancer|January 1, 1989
[What are the prognostic factors in operable breast cancer without histologic axillary lymph node invasiveness. Results of an uni- and multifactorial analysis]B Chevallier, F Heintzman, V Mosseri, et al.
American Journal of Clinical Oncology|April 1, 1994
Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study GroupT Conroy, P Cappelaere, M Fabbro, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of CancerP Hurteloup, J P Armand, M Schneider, et al.
Cancer|December 15, 1988
Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysisB Chevallier, F Heintzmann, V Mosseri, et al.
Bulletin Du Cancer|July 1, 1993
[Treatment of advanced breast cancer in postmenopausal women with droloxifene: results of a double-blind phase II trial for dose determination]B Chevallier, M Spielmann, M Marty, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2003
[Marfan syndrome]G Jondeau, C Boileau, B Chevallier, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1997
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapyB Chevallier, P Cappelaere, T Splinter, et al.
European Urology|January 1, 1993
Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trialC Chevreau, J P Droz, J L Pico, et al.
HIV Medicine|April 4, 2026
Late HIV diagnosis and subsequent time to antiretroviral initiation and viral suppression in a large London HIV centreTheodore R B Chevallier, Fiona C Lampe, Margaret A Johnson, et al.
Pageof 19